COMP <GO>
CPT vs MS // ALTMAN Z-SCORE & DEBT/EQUITY
Camden Property Trust (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CPT 11
— MS 4
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: CPT
LAST: $100.69 (-0.25%) • MKT CAP: $10.15B
balance-sheet
2.01
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
balance-sheet
0.46
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPT VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPT | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 41.00% | -71.00 | MS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.90% | 3.00% | +2.90 | CPT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 31.0x | -5.30 | CPT | /valuation <GO> |
| Free Cash Flow Yield | 8.14% | -7.25% | +15.39 | CPT | /fcf-yield <GO> |
| Operating Margin | 75.00% | 24.60% | +50.40 | CPT | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 20.20% | +47.80 | CPT | /net-margins <GO> |
| Revenue Growth (YoY) | 81.70% | 5.50% | +76.20 | CPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.54% | 2.21% | +2.33 | CPT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.01 | 0.46 | +1.55 | CPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | CPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 7.00% | +0.40 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 43.3 | +9.22 | CPT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 1.04 | +0.11 | CPT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.2x | 16.5x | +5.70 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.15B | $298.41B | -$288.26B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPT REV | MS REV | CPT GROSS % | MS GROSS % | CPT FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.0M | $0 | -4270.4% | — | $826.0M | -$17.89B |
| FY 2024 | $7.1M | $0 | -7729.7% | — | $774.6M | $1.36B |
| FY 2023 | $3.5M | $0 | 44.0% | — | $794.8M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPT // BETA 1.15
MS // BETA 1.04